Y mAbs Therapeutics
Biotechnology
Healthcare
YMAB
44.63 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
5.19
52 week high
15.69
high
5.24
52 week low
3.64
previous Close
5.13
P/E ratio
market cap
365 M
div yield
0
net incoming
-7.00 M
24.34 %
net profit margin
-37.91 %
2.00 %
operating incoming
-8.57 M
12.47 %
net change in cash
-9.68 M
-570.78 %
cash on hand
68.12 M
-12.45 %
cost of revenue
2.25 M
-25.41 %
top